Drawing for COBAS PLEX

USPTO serial 97703899

COBAS PLEX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ADEJUNMOBI, AKIN T
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with COBAS PLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mona Gupta

Mona Gupta Roche Diagnostics Operations, Inc.9115 Hague RoadIndianapolis, IN 46250United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biological and biochemical preparations for scientific and research purposes; Assays and reagents for scientific and research purposes; In vitro diagnostic agents for scientific and research purposes; Control solutions for calibration and monitoring the accuracy and function of laboratory instruments and test results; Assays and reagents for scientific or medical research use; Kits consisting primarily of reagents and diagnostic preparations for research purposeACTIVE—
005Chemical, biological and biochemical preparations for the analysis of biological samples for medical purposes; medical diagnostic assays and reagents for the analysis of biological samples for clinical or medical purposes; Diagnostic reagents and preparations for medical purposes; In vitro diagnostic agents for the analysis of biological samples for medical purposes; Kits consisting primarily of reagents and diagnostic preparations for clinical and medical diagnostic purposesACTIVE—
009Laboratory instruments for use in research and science, namely, analyzers for the analysis of biological samples for scientific or medical research use; Laboratory instruments, namely, clinical chemistry analyzers and immunochemistry analyzers for the analysis of biological samples for the presence, absence, or quantity of medically significant analytes for scientific or medical research purposes; Laboratory equipment, namely, automated sample handling equipment comprised of recorded software for automating diagnostic laboratory processes, not for medical purposes and bar code readers; Downloadable computer software for the provision of automated diagnostic laboratory processes for medical and diagnostic purposes; Downloadable computer software for use with laboratory instruments, namely, for use in providing remote automated control, connection, data analysis and data management between central laboratory instrumentation and remote clinical laboratory instrumentation; Computer hardware and downloadable computer software for collecting, storing, analyzing and reporting biological information for use in the fields of scientific, diagnostics and clinical research; computer hardware and downloadable computer software for sample tracking and for managing projects, laboratory workflow and data for use in the fields of scientific, diagnostic and clinical research; computer hardware and downloadable computer software for collecting, storing, analyzing and reporting biological information, sample tracking, managing products, laboratory workflow and data for clinical diagnostic purposesACTIVE—
010Medical apparatus and instruments for medical and diagnostic purposes for the analysis of biological samples; Medical apparatus, namely, clinical chemistry analyzers and immunochemistry analyzers for use in the analysis of biological samples for the presence, absence, or quantity of medically significant analytes for clinical medical diagnostic purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 14, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 14, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 23, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 23, 2026EX5GSOU EXTENSION 5 GRANTED—
Jun 18, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 2, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 1, 2026EXT5SOU EXTENSION 5 FILED—
Aug 5, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 4, 2025EX4GSOU EXTENSION 4 GRANTED—
Aug 4, 2025EXT4SOU EXTENSION 4 FILED—
Aug 4, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 29, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 29, 2024EX3GSOU EXTENSION 3 GRANTED—
Oct 29, 2024EXT3SOU EXTENSION 3 FILED—
Oct 29, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 10, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 10, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 10, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 2, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 2, 2024EX2GSOU EXTENSION 2 GRANTED—
Aug 2, 2024EXT2SOU EXTENSION 2 FILED—
Aug 2, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 31, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 29, 2024EX1GSOU EXTENSION 1 GRANTED—
Jan 29, 2024EXT1SOU EXTENSION 1 FILED—
Jan 29, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 8, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 13, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 13, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 24, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 11, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 8, 2023DOCKASSIGNED TO EXAMINER—
Jan 3, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 8, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance